XTL Biopharmaceuticals Ltd ADR is a biotechnology business based in the US. XTL Biopharmaceuticals Ltd ADR shares (XTLB) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in XTL Biopharmaceuticals Ltd ADR
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – XTLB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

What's in this guide?
XTL Biopharmaceuticals Ltd ADR stock price (NASDAQ: XTLB)
Use our graph to track the performance of XTLB stocks over time.XTL Biopharmaceuticals Ltd ADR shares at a glance
Latest market close | $1.49 |
---|---|
52-week range | $1.35 - $6.69 |
50-day moving average | $1.81 |
200-day moving average | $2.70 |
Wall St. target price | $30.00 |
PE ratio | 0 |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $0.00 |
Buy XTL Biopharmaceuticals Ltd ADR shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy XTL Biopharmaceuticals Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
XTL Biopharmaceuticals Ltd ADR price performance over time
Historical closes compared with the close of $1.49 from 2022-07-01
1 week (2022-06-24) | -4.49% |
---|---|
1 month (2022-06-03) | -13.37% |
3 months (2022-04-01) | -34.65% |
6 months (2022-01-03) | -48.26% |
1 year (2021-07-02) | -62.18% |
---|---|
2 years (2020-07-02) | -6.42% |
3 years (2019-07-03) | 1.866 |
5 years (2017-07-03) | 3.39 |
XTL Biopharmaceuticals Ltd ADR financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -9.4% |
Return on equity TTM | 12.83% |
Profit margin | 0% |
Book value | $1.10 |
Market capitalisation | $8.3 million |
TTM: trailing 12 months
XTL Biopharmaceuticals Ltd ADR share dividends
We're not expecting XTL Biopharmaceuticals Ltd ADR to pay a dividend over the next 12 months.
Have XTL Biopharmaceuticals Ltd ADR's shares ever split?
XTL Biopharmaceuticals Ltd ADR's shares were split on a 1:5 basis on 9 February 2017. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your XTL Biopharmaceuticals Ltd ADR shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for XTL Biopharmaceuticals Ltd ADR shares which in turn could have impacted XTL Biopharmaceuticals Ltd ADR's share price.
XTL Biopharmaceuticals Ltd ADR share price volatility
Over the last 12 months, XTL Biopharmaceuticals Ltd ADR's shares have ranged in value from as little as $1.35 up to $6.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while XTL Biopharmaceuticals Ltd ADR's is 1.0439. This would suggest that XTL Biopharmaceuticals Ltd ADR's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
XTL Biopharmaceuticals Ltd ADR overview
XTL Biopharmaceuticals Ltd. , a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995.
Frequently asked questions
What percentage of XTL Biopharmaceuticals Ltd ADR is owned by insiders or institutions?Currently 14.448% of XTL Biopharmaceuticals Ltd ADR shares are held by insiders and 8.483% by institutions. When does the fiscal year end for XTL Biopharmaceuticals Ltd ADR?
XTL Biopharmaceuticals Ltd ADR's fiscal year ends in December. Where is XTL Biopharmaceuticals Ltd ADR based?
XTL Biopharmaceuticals Ltd ADR's address is: 5 Badner Street, Ramat Gan, Israel, 5218102 What is XTL Biopharmaceuticals Ltd ADR's ISIN number?
XTL Biopharmaceuticals Ltd ADR's international securities identification number is: US98386D3070 What is XTL Biopharmaceuticals Ltd ADR's CUSIP number?
XTL Biopharmaceuticals Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 98386D109
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert